The DeciBiome
Join the DeciBio team as they discuss industry news and hot topics in the precision medicine space with some of the brightest in the industry.
Episodes
6 episodes
Bringing back the Mammoth: featuring Colossal Biosciences’ CEO Ben Lamm and Scientist Christopher Mason
The DeciBio team interviews Colossal Biosciences’ co-founder and CEO, Ben Lamm and Colossal Biosciences' Scientific Advisor and Professor of Computational Genomics, Christopher Mason, to discuss the science behind Colossal's mission to de-extin...
•
28:34
Accelerating Precision Medicine Through Biomarker Testing: A DeciBio Expert Panel Discussion
How do you maximize clinical trial samples, especially as we face a growing need for biomarker testing? Learn more about these precision medicine questions as one of our experts interviews a panel of leaders from pharma, clinical testing, and h...
•
38:07
Liquid Biopsy 2023 Forecast: Clinicians' Perspectives
Clinicians from top medical centers in the United States share their predictions for the Liquid Biopsy (LBx) industry in 2023. Our specialists, including Partner Andrew Aijian, chime in with LBx trends, adoption, and activities, based on our wo...
•
14:59
Next Generation mRNA Therapies Post COVID-19 with Jacob Becraft of Strand Therapeutics
On this episode, Alex Amram and Joe Daccache interview special guest, Jacob Becraft the CEO and co-founder of Strand Therapeutics— a company leveraging synthetic biology to create the next-generation of m...
•
Episode 5
•
39:20